tradingkey.logo

LeMaitre Vascular Inc

LMAT
View Detailed Chart
86.600USD
-1.950-2.20%
Close 10/31, 16:00ETQuotes delayed by 15 min
1.96BMarket Cap
41.61P/E TTM

LeMaitre Vascular Inc

86.600
-1.950-2.20%
Intraday
1m
30m
1h
D
W
M
D

Today

-2.20%

5 Days

-2.71%

1 Month

-1.04%

6 Months

-4.56%

Year to Date

-6.01%

1 Year

-2.75%

View Detailed Chart

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

LeMaitre Vascular Inc's Score

Industry at a Glance

Industry Ranking
17 / 210
Overall Ranking
74 / 4621
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 10 analysts
Buy
Current Rating
104.625
Target Price
+17.73%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

LeMaitre Vascular Inc Highlights

StrengthsRisks
LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Its portfolio of product lines is primarily used to treat vascular disease, of which most are used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy catheters, occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. The Company’s principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. The Company sells its products and services primarily through a direct sales force.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 36.01% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 219.86M.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 32.65%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 32.65%.
Undervalued
The company’s latest PE is 42.37, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 21.62M shares, decreasing 3.56% quarter-over-quarter.
Held by HACAX
Star Investor HACAX holds 6.51K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.42.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

LeMaitre Vascular Inc Info

LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Its portfolio of product lines is primarily used to treat vascular disease, of which most are used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy catheters, occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. The Company’s principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. The Company sells its products and services primarily through a direct sales force.
Ticker SymbolLMAT
CompanyLeMaitre Vascular Inc
CEOMr. George W. Lemaitre
Websitehttps://www.lemaitre.com/
KeyAI